Novo Nordisk (NVO) Hit with Investor Lawsuit Over CagriSema Obesity Drug – Hagens BermanGlobeNewsWire • 02/24/25
Investors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – NVOAccesswire • 02/24/25
NVO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 02/24/25
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVOGlobeNewsWire • 02/23/25
A Lawsuit Has Been Filed Against Novo Nordisk A/S For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmAccesswire • 02/21/25
NVO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 02/21/25
Shareholders that Lost Money on Novo Nordisk A/S(NVO) Should Contact Levi & Korsinsky about Pending Class Action - NVOAccesswire • 02/20/25
Investors in Novo Nordisk A/S Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights – NVOGlobeNewsWire • 02/20/25
NVO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Novo Nordisk A/S to Contact the Firm Today!Accesswire • 02/20/25
Novo Nordisk A/S Sued for Securities Law Violations - Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVOPRNewsWire • 02/20/25
Novo Nordisk A/S Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmAccesswire • 02/19/25
Levi & Korsinsky Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – NVGlobeNewsWire • 02/18/25
Shareholders that lost money on Novo Nordisk A/S (NVO) should contact Levi & Korsinsky about pending Class Action - NVOAccesswire • 02/18/25
Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP BiosciencesReuters • 02/18/25
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOAccesswire • 02/16/25
Novo Nordisk A/S Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - NVOAccesswire • 02/14/25